• Barkmeier J. M. and Luschei E. S. (2000) Quantitative analysis of the anatomy of the epineurium of the canine recurrent laryngeal nerve. J. Anat. 196, 85101.
  • Chrast R., Saher G., Nave K. A. and Verheijen M.H. (2011) Lipid metabolism in myelinating glial cells: lessons from human inherited disorders and mouse models. J. Lipid Res. 52, 419434.
  • Deng Y. and Scherer P. E. (2010) Adipokines as novel biomarkers and regulators of the metabolic syndrome. Ann. N. Y. Acad. Sci. 1212, E1E19.
  • He W., Barak Y., Hevener A. et al. (2003) Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle. Proc. Natl Acad. Sci. USA 100, 1571215717.
  • Huxley C., Passage E., Robertson A. M. et al. (1998) Correlation between varying levels of PMP22 expression and the degree of demyelination and reduction in nerve conduction velocity in transgenic mice. Hum. Mol. Genet. 7, 449458.
  • Langner C. A., Birkenmeier E. H., Roth K. A., Bronson R. T. and Gordon J. I. (1991) Characterization of the peripheral neuropathy in neonatal and adult mice that are homozygous for the fatty liver dystrophy (fld) mutation. J. Biol. Chem. 266, 1195511964.
  • Lupski J. R., de Oca-Luna R. M., Slaugenhaupt S. et al. (1991) DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell, 66, 219232.
  • Maeda M. H., Mitsui J., Soong B. W. et al. (2012) Increased gene dosage of myelin protein zero causes Charcot-Marie-Tooth disease. Ann. Neurol. 71, 8492.
  • Magyar J. P., Martini R., Ruelicke T., Aguzzi A., Adlkofer K., Dembic Z., Zielasek J., Toyka K. V. and Suter U. (1996) Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage. J. Neurosci. 16, 53515360.
  • Moayeri N. and Groen G. J. (2009) Differences in quantitative architecture of sciatic nerve may explain differences in potential vulnerability to nerve injury, onset time, and minimum effective anesthetic volume. Anesthesiology 111, 11281134.
  • Nadra K., de Preux Charles A. S., Medard J. J. et al. (2008) Phosphatidic acid mediates demyelination in Lpin1 mutant mice. Genes Dev. 22, 16471661.
  • Nadra K., Quignodon L., Sardella C., Joye E., Mucciolo A., Chrast R. and Desvergne B. (2010) PPARgamma in placental angiogenesis. Endocrinology 151, 49694981.
  • Parkinson D. B., Dickinson S., Bhaskaran A., Kinsella M. T., Brophy P. J., Sherman D. L., Sharghi-Namini S., Duran Alonso M. B., Mirsky R. and Jessen K. R. (2003) Regulation of the myelin gene periaxin provides evidence for Krox-20-independent myelin-related signalling in Schwann cells. Mol. Cell. Neurosci. 23, 1327.
  • Parmantier E., Lynn B., Lawson D., Turmaine M., Namini S. S., Chakrabarti L., McMahon A. P., Jessen K. R. and Mirsky R. (1999) Schwann cell-derived desert hedgehog controls the development of peripheral nerve sheaths. Neuron 23, 713724.
  • Peterfy M., Phan J., Xu P. and Reue K. (2001) Lipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin. Nat. Genet. 27, 121124.
  • Pina-Oviedo S. and Ortiz-Hidalgo C. (2008) The normal and neoplastic perineurium: a review. Adv. Anat. Pathol. 15, 147164.
  • de Preux Charles A. S., Verdier V., Zenker J., Peter B., Medard J. J., Kuntzer T., Beckmann J. S., Bergmann S. and Chrast R. (2010) Global transcriptional programs in peripheral nerve endoneurium and DRG are resistant to the onset of type 1 diabetic neuropathy in Ins2 mice. PLoS ONE 5, e10832.
  • de Preux A. S., Goosen K., Zhang W. et al. (2007) SREBP-1c expression in Schwann cells is affected by diabetes and nutritional status. Mol. Cell. Neurosci. 35, 525534.
  • Rosen E. D., Walkey C. J., Puigserver P. and Spiegelman B. M. (2000) Transcriptional regulation of adipogenesis. Genes Dev. 14, 12931307.
  • Saher G., Brügger B., Lappe-Siefke C., Möbius W., Tozawa R., Wehr M. C., Wieland F., Ishibashi S. and Nave K. A. (2005) High cholesterol level is essential for myelin membrane growth. Nat. Neurosci. 8, 468475.
  • Verheijen M. H., Chrast R., Burrola P. and Lemke G. (2003) Local regulation of fat metabolism in peripheral nerves. Genes Dev. 17, 24502464.
  • Verheijen M. H., Camargo N., Verdier V. et al. (2009) SCAP is required for timely and proper myelin membrane synthesis. Proc. Natl Acad. Sci. USA 106, 2138321388.
  • Wrabetz L., Feltri M. L., Quattrini A. et al. (2000) P(0) glycoprotein overexpression causes congenital hypomyelination of peripheral nerves. J. Cell Biol. 148, 10211034.
  • Yen C. L., Stone S. J., Koliwad S., Harris C. and Farese Jr R. V. (2008) Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis. J. Lipid Res. 49, 22832301.
  • Zenker J., Poirot O., de Preux Charles A. S. et al. (2012) Altered distribution of juxtaparanodal Kv1.2 subunits mediates peripheral nerve hyperexcitability in type 2 diabetes mellitus. J. Neurosci. 32, 74937498.